ARTIAM BIO INC.
Biotech · Private
APJ receptor agonist therapeutic (APT101) for systemic sclerosis-associated pulmonary fibrosis
- Grants
- $1.5M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Therapeutic Strategy for NASH | $256,475 | |
| Federal grant | Department of Health and Human Services · Phase I · Treatment for cannabis use disorder | $319,898 | |
| Federal grant | Department of Health and Human Services · Phase I · Therapy For Alcohol Use Disorder | $368,673 | |
| Federal grant | Department of Health and Human Services · Phase I · Validation of APT101 for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in an Aging Murine Model | $292,279 | |
| Federal grant | Department of Health and Human Services · Phase I · Validation of APT101 for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in an Aging Murine Model | $279,513 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2684 | Ironfist Therapeutics, Inc. | — | $2K |
| 2685 | Eyebiotech Ltd | — | $486 |
| 2686 | RevOpsis Holdings LLC | — | $1 |
| 2687 | ARTIAM BIO INC. | — | — |
| 2688 | RegenX LLC | — | — |
| 2689 | THINK BIOSCIENCE, INC. | — | — |
| 2690 | LAB11 THERAPEUTICS INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.